Prospective Multi-Center Trial for FemBloc Permanent Birth Control
NCT05977751
This study is recruiting at 12 US sites in 9 states, according to its ClinicalTrials.gov record last updated .
Summary
Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Contraception
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 21 to 50 years
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- Femasys Inc.
- Last updated on ClinicalTrials.gov
- October 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- New Horizons Clinical Trials · Chandler, AZ
California · 2
- Stanford University · Palo Alto, CA
- University of California Davis · Sacramento, CA
Georgia · 2
- Midtown OB GYN North · Columbus, GA
- Atrium Health Navicent · Macon, GA
Idaho · 1
- Rosemark WomenCare Specialists · Idaho Falls, ID
New York · 2
- Maimonides Medical Center · Brooklyn, NY
- Columbia University Medical Center · New York, NY
Ohio · 1
- Seven Hills Women's Health Centers · Cincinnati, OH
Tennessee · 1
- Chattanooga Medical Research LLC · Chattanooga, TN
Texas · 1
- Baylor Scott & White Research Institute · Temple, TX
Utah · 1
- University of Utah · Salt Lake City, UT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.